Local view for "http://purl.org/linkedpolitics/eu/plenary/1999-11-16-Speech-2-151"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.19991116.9.2-151"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"This is the first step under the old Article169 procedure which is now under Article 226. Provision is made in that Article for sending a letter of this type prior to the actual institution of the proceedings. But it is part of the infringement proceedings and is regarded as the first step. It sets out in chronological form the present position, how we have reached this stage; it then sets out the legal position and then requests France to respond and set out whatever arguments it wishes to advance in its reply. All this is to be done within a period of two weeks.
Within the discussions over the last few weeks, a number of issues were discussed, as you are probably aware, and one of the issues that was identified was the question of tests, as you rightly identify in your question. You draw attention to the fact that during my hearings on 3 September before the Committee on the Environment, Public Health and Consumer Policy, I mentioned that it was my intention to establish diagnostic testing for BSE on an EU-wide basis. That is still my intention. That fact was also drawn to the attention of the parties who were involved in these discussions over the last couple of weeks.
As I mentioned on that occasion, one of the purposes of establishing such a testing system is to ensure that there is an equal testing system throughout the European Union so as to identify the levels of infectivity throughout the EU, and in particular to identify what further measures may be necessary. The removal of SRMs would be one particular issue I have in mind in relation to that.
On the question of identification and labelling, one of the important issues that we discussed over the last few weeks was the requirement contained in the legislation for traceability. That is an important issue. It was discussed in Florence. It also forms part of the DBES and is in the forefront of our minds in relation to this and has been incorporated into our discussions."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples